{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:14:14Z","timestamp":1792793654561,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To analyze the clinical features, treatment, and prognosis of chronic active Epstein-Barr virus infection (CAEBV) with central nervous system (CNS) involvement in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients with CAEBV admitted to Beijing Children\u2019s Hospital, Capital Medical University, were enrolled in this study from January 2017 to December 2020. They were divided into a CNS group and a non-CNS group based on the presence of CNS involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-two patients developed CNS disease, accounting for 23.9% (22\/92) of CAEBV patients in the same period. Of these, only 2 of 22 patients presented initially with neurologic symptoms in the CNS group, and they all improved after treatment. Cerebrospinal fluid (CSF) examination demonstrated normal protein concentration and cell number in all patients with CNS involvement. Only 7 patients were positive for CSF EBV-DNA. Twenty-one patients had neuroimaging abnormalities, such as white matter signal abnormalities, encephalography or calcification. In the CNS group, 7 (31.8%) patients died, including 5 who died of active hemophagocytic lymphohistiocytosis, 1 died of unrelated causes, and 1 died of respiratory failure caused by pulmonary lymphoproliferative disease progression after transplantation. The 3-year overall survival was lower in the CNS group than in the non-CNS group (63.6% \u00b1 11.9% versus 86.9% \u00b1 4.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.027). Hemophagocytic lymphohistiocytosis (HLH) is an independent risk factor for CNS involvement in patients with CAEBV (OR = 2.946, 95% CI: 1.042\u20138.335,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.042). Compared with the non-CNS group, blood EBV-DNA loads and CD4+\/CD8+ ratio of T lymphocytes in the CNS group were higher (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), while fibrinogen levels and natural killer (NK)-cell activity were lower (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.047). Children with CAEBV were more likely to develop CNS diseases with low NK-cell activity (NK-cell activity &lt; 14.00%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.023) or high alanine aminotransferase (ALT) levels (ALT levels &gt; 40 U\/L,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.032).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CAEBV with CNS involvement has nonspecific clinical manifestations, laboratory data, neuroimaging but has a worse prognosis. Blood fibrinogen levels and NK-cell activity in CAEBV children with CNS involvement are lower than in those without CNS involvement. In contrast, blood EBV-DNA loads and CD4+\/CD8+ ratio of T lymphocytes are higher. Children with CAEBV who presented with HLH, NK-cell activity &lt;14.00%, serum ALT &gt;40 U\/L and high-blood EBV-DNA loads are prone to develop CNS diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003738","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:02:16Z","timestamp":1670410936000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Chronic Active Epstein-Barr Virus Infection With Central Nervous System Involvement in Children: A Clinical Study of 22 Cases"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-5619","authenticated-orcid":false,"given":"Wenxin","family":"Ou","sequence":"first","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunze","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Wei","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Ma","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Lian","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"Hematologic Disease Laboratory, Beijing Pediatric Research Institute; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"Hematologic Disease Laboratory, Beijing Pediatric Research Institute; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"},{"name":"Hematologic Disease Laboratory, Beijing Pediatric Research Institute; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Major Disease in Children, Ministry of Education; Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"R1-20260716","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection.","volume":"102","author":"Dunmire","year":"2018","journal-title":"J Clin Virol"},{"key":"R2-20260716","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein-Barr virus disease.","volume":"8","author":"Kimura","year":"2017","journal-title":"Front Immunol"},{"key":"R3-20260716","doi-asserted-by":"crossref","first-page":"32023202","DOI":"10.3390\/cancers12113202","article-title":"Chronic active Epstein-Barr virus infection: is it immunodeficiency, malignancy, or both?","volume":"12","author":"Fujiwara","year":"2020","journal-title":"Cancers"},{"key":"R4-20260716","first-page":"64","article-title":"EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.","volume":"10","author":"Brett","year":"2017","journal-title":"Hum Pathol (N Y)"},{"key":"R5-20260716","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fped.2019.00014","article-title":"Advances in the study of chronic active epstein-barr virus infection: clinical features under the 2016 WHO Classification and Mechanisms of Development.","volume":"7","author":"Arai","year":"2019","journal-title":"Front Pediatr"},{"key":"R6-20260716","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11940-017-0439-4","article-title":"How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis?","volume":"19","author":"Horne","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"R7-20260716","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1468-1331.2010.02970.x","article-title":"Viral meningoencephalitis: a review of diagnostic methods and guidelines for management.","volume":"17","author":"Steiner","year":"2010","journal-title":"Eur J Neurol"},{"key":"R8-20260716","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.10321","article-title":"Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system.","volume":"52","author":"Weinberg","year":"2002","journal-title":"Ann Neurol"},{"key":"R9-20260716","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20260716","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"R11-20260716","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13023-021-01909-y","article-title":"Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.","volume":"16","author":"Ma","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R12-20260716","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"R13-20260716","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bjh.14339","article-title":"Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.","volume":"175","author":"Worth","year":"2016","journal-title":"Br J Haematol"},{"key":"R14-20260716","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.","volume":"17","author":"Munger","year":"2011","journal-title":"Mult Scler"},{"key":"R15-20260716","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s10096-011-1261-7","article-title":"Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity.","volume":"30","author":"Kleines","year":"2011","journal-title":"Eur J Clin Microbiol Infect. Dis"},{"key":"R16-20260716","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2008.07.035","article-title":"An autopsy case of chronic active Epstein-Barr virus infection (CAEBV): distribution of central nervous system (CNS) lesions.","volume":"275","author":"Kobayashi","year":"2008","journal-title":"J Neurol Sci"},{"key":"R17-20260716","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00043426-199901000-00009","article-title":"Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection.","volume":"21","author":"Ohga","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"R18-20260716","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-Cell lymphoproliferative diseases.","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"R19-20260716","first-page":"1224","article-title":"Epstein-barr virus-associated encephalitis in a case-series of more than 40 patients.","volume":"71","author":"Dyachenko","year":"2018","journal-title":"Wiad Lek"},{"key":"R20-20260716","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/tid.12090","article-title":"Epstein-Barr virus (EBV) load in cerebrospinal fluid and peripheral blood of patients with EBV-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation.","volume":"15","author":"Liu","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R21-20260716","first-page":"367","article-title":"Cerebrospinal fluid findings in chronic active Epstein-Barr virus infection with central nervous system involvement.","volume":"59","author":"Yoshimori","year":"2018","journal-title":"Rinsho Ketsueki"},{"key":"R22-20260716","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","article-title":"How we treat chronic active Epstein-Barr virus infection.","volume":"105","author":"Sawada","year":"2017","journal-title":"Int J Hematol"},{"key":"R23-20260716","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"R24-20260716","first-page":"12797","article-title":"Peripheral blood lymphocyte counts in patients with infectious mononucleosis or chronic active Epstein-Barr virus infection and prognostic risk factors of chronic active Epstein-Barr virus infection.","volume":"13","author":"Lin","year":"2021","journal-title":"Am J Transl Res"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:02:14Z","timestamp":1784224934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003738","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,11]]}}}